Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination

Detalles Bibliográficos
Autores principales: Pothast, Cilia R., Hofsink, Quincy, Haggenburg, Sabine, Bhoekhan, Michel, Haverkate, Nienke J.E., Dijkland, Romy C., van Dijk, Kayleigh, Falkenburg, Frederik J.H., Broers, Annoek E.C., van Doesum, Jaap, van Binnendijk, Robert S., den Hartog, Gerco, Burger, Judith A., Bouhuijs, Joey H., Lissenberg-Witte, Birgit I., Smits, Gaby P., Wouters, Dorine, van Leeuwen, Ester M.M., Bontkes, Hetty J., Kootstra, Neeltje A., Zweegman, Sonja, Kater, Arnon P., Groen, Kaz, van Meerten, Tom, Mutsaers, Pim G.N.J., Beaumont, Tim, van Gils, Marit J., Goorhuis, Abraham, Hazenberg, Mette D., Nijhof, Inger S., Heemskerk, Mirjam H.M., Rutten, Caroline E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665207/
http://dx.doi.org/10.1182/blood-2022-169164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665207/
http://dx.doi.org/10.1182/blood-2022-169164

Ejemplares similares